Navigation Links
NIAID media tip sheet: Annual Meeting of the American Academy of Allergy, Asthma and Immunology
Date:2/24/2010

WHAT: The 2010 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) brings together leading allergists and immunologists from around the world.

WHO: Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will be presenting their latest research findings at the AAAAI Annual Meeting. For more than 60 years, NIAID has supported allergy and immunology research at U.S. and international institutions and conducted studies within its own laboratories to improve the health of millions of people.

WHEN: February 26 to March 2, 2010

WHERE: Ernest N. Morial Convention Center, New Orleans, La.

Presentation Tips:

Below are advance summaries of select presentations describing NIAID-funded research. The information contained in the summaries is embargoed until the time of presentation.

Findings from the Inner-City Anti-IgE Therapy for Asthma Study

Asthma affects as many as 20 million Americans, but it disproportionately affects childrenespecially African-American and Hispanic childrenwho live in inner-city environments. Over the past two decades, NIAID has supported research programs aimed at developing asthma interventions tailored to children living in inner-city areas. The Inner-City Asthma Consortium (ICAC), a network of eight clinical and two basic research sites nationwide, is a critical part of that effort. ICAC investigators designed and conducted the Inner-City Anti-IgE Therapy for Asthma (ICATA) study in which children with mild to severe asthma were given omalizumab, a monoclonal antibody that targets immunoglobulin E (IgE), an antibody that triggers allergic reactions and inflammation in the lungs. The goal of this study was to determine if adding omalizumab to the asthma treatment directed by the National Asthma Education and Prevention Program Guidelines (

Contact: Julie Wu
wujuli@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. NIAID announces new human immunology research awards to help fight emerging infectious diseases
2. NIAID announces vaccine adjuvant discovery contracts
3. Rib-X Pharmaceuticals Receives Award from NIAID to Develop Antibiotic Treatment for Gonorrhea
4. NIAID launches 2009 H1N1 influenza vaccine trial in pregnant women
5. NIAID funds clinical trials that address the problem of antimicrobial resistance
6. NIAID Awards New Grant to Expand Studies of Peregrines Anti-PS Antibodies to Treat Viral Hemorrhagic Fevers
7. NIAID to fund new human immune profiling research centers
8. NIAID media availability: Still searching for predictors of asthma attacks
9. NIAID set to launch clinical trials to test 2009 H1N1 influenza vaccine candidates
10. NIAID media availability: New strategy proposed for designing antibody-based HIV vaccine
11. J. Craig Venter Institute Awarded $43 Million, Five Year Contract From NIAID to Continue to Develop and Provide Sequencing, Genotyping, and Bioinformatics Expertise and Services in Infectious Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Chicago, IL (PRWEB) June 19, 2013 Brand new ... Pakulski for the 4 day sale on the Hypertrophy Max program. ... the next 24 hours so those that are interested must act ... The all new Hypertrophy Max bonus is a free 12 month ... Del Monte. , According to Ryan Davids "Live Large TV is ...
(Date:6/19/2013)... A man returning from war is not likely to ... his debut book titled RED DANCER JOURNEY, author Rafael Fraguada pens ... home, looking for the right place and people to mend his ... from the Vietnam War, returns to New York City, he meets ... Wings, a wealthy acquaintance from a tiny Midwest college they both ...
(Date:6/19/2013)... WV (PRWEB) June 19, 2013 The ... individual used the sauna but the overall experience for ... to be positive health-wise. , Mr Mouw, whose Virgina-based ... to the Society’s statement by saying that the type ... learned of a number of counterfeit imitations which frankly, ...
(Date:6/19/2013)... New York, NY (PRWEB) June 19, 2013 ... at Mount Sinai demonstrated several new studies at ... Expo (ENDO) from June 15-18 in San Francisco.     ... self-management, as well as the role of prostastic acid ... new molecules that can stimulate the thyroid gland; revealed ...
(Date:6/19/2013)... June 19, 2013 CCA , ... Dr. John Baxter to Vice President, Health Services, effective ... Director, Mental Health Services for CCA. He will ... honor and great privilege to lead CCA's dedicated team ... opportunity to serve society and our partners as we ...
Breaking Medicine News(10 mins):Health News:New Hypertrophy Max Bonus Just Released and Only Available for 24 Hours 2Health News:Rafael Fragauda’s New Book Underlines Post Traumatic Stress Disorder 2Health News:Health Benefits of Saunas Only Viable with Properly Constructed Models, Warns Manufacturer 2Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 2Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 3Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 4Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 5Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 6Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 7Health News:CCA Names Dr. John Baxter Vice President, Health Services 2
... serious concern over growing problems due to use of ... Empowerment Meira Kumar today suggested effective monitoring // and ... ,There is a need to establish effective drug use ... the northeastern region,Kumar said while releasing a monograph on ...
... cholesterol-decreasing medications like millions of Americans. However she does ... she is taking part in a different clinical study ... view the benefits of Lipitor on the immune system ... sclerosis (ALS). ,Physicians at the Methodist NI's ...
... 24 years, bled to death following delivery of a stillborn baby, ... mother’s death, would now be offered a ?300,000 compensation for the ... duty in her case. ,She was admitted to the ... told that her baby had passed away in the uterus and ...
... business model for the state-of-the-art Institute of Liver and Biliary ... ,The model approved by the Cabinet at its meeting ... to be self-sufficient in nine years' time, an official spokesman ... medical equipment would be borne by Delhi Government., ,The ...
... ,The effects of zolpidem on three patients were studied for ... rehabilitation experts reveal that they are in a condition where ... interaction and responses, having signs of movement, sleep and breathing ... the patients every morning. ,An improvement was seen ...
... be a ray of hope for men, who are holed ... from available treatment measures//. An exercise by scientists involving rabbits, ... engineer an artificial penis, may be the answer for non-treatable ... adult male rabbits were introduced with a graft made from ...
Cached Medicine News:Health News:Study Aims At The Immune System In Patients With Lou Gehrig's Disease 2Health News:?300,000 Compensation For Family After Death Of Daughter Following Deliver 2
(Date:6/19/2013)... June 19, 2013 ... market research report is available in ... Licensing, Investments and M&A Deals and ... http://www.reportlinker.com/p0925641/Partnerships-Licensing-Investments-and-MA-Deals-and-Trends-for-May-2013-in-Pharmaceuticals.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Investment_Banking ... Deals and Trends for May 2013 ...
(Date:6/19/2013)... 2013 A decade-long JDRF-funded study led by ... Germany , is providing a deeper ... of developing type 1 diabetes (T1D), highlighting the importance ... The study, "Seroconversion to Multiple Islet Autoantibodies and Risk ... in The Journal of the American Medical Association ...
(Date:6/19/2013)...   BioCision , a leader in advanced ... many areas of medical and scientific research, announced ... U.S. Patent Office that apply to two of ... handling to ensure the consistency of test conditions ... Patent number 8,388,912 covers CoolSink® ...
Breaking Medicine Technology:Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 2Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 3Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 4Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 5Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 6Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 7Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 8Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 9Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 10Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 11Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 12Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 13New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 2New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 3BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research 2
... N.J., June 15, 2011 Cordis Corporation, ... interventional vascular technology, today announced it will no longer ... in order to focus on other cardiovascular therapies where ... the manufacture of CYPHER® and CYPHER SELECT® Plus Sirolimus-Eluting ...
... American Academy of Family Physicians Foundation is excited ... Award winners. These awards recognize family medicine residency ... their communities through creative solutions. Monetary grants and ... presented to 16 residents from the following programs: ...
Cached Medicine Technology:Cordis Announces Discontinuation of NEVO™ Sirolimus-Eluting Coronary Stent 2Cordis Announces Discontinuation of NEVO™ Sirolimus-Eluting Coronary Stent 3Cordis Announces Discontinuation of NEVO™ Sirolimus-Eluting Coronary Stent 4Family Medicine Residency Programs Recognized for Improving Childhood and Adult Immunizations Rates in Underserved Communities 2Family Medicine Residency Programs Recognized for Improving Childhood and Adult Immunizations Rates in Underserved Communities 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: